Jeremy Grantham's APGE Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 137,395 shares of Apogee Therapeutics, Inc. (APGE) worth $18.24 M, representing 0.04% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jeremy Grantham has initiated a new position in APGE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Apogee Therapeutics (APGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Apogee Therapeutics (APGE) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +137,395 | New Buy | 137,395 | $132.73 |
Jeremy Grantham's Apogee Therapeutics Investment FAQs
Jeremy Grantham first purchased Apogee Therapeutics, Inc. (APGE) in Q2 2026, acquiring 137,395 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Apogee Therapeutics, Inc. (APGE) for 1 quarters since Q2 2026.
Jeremy Grantham's largest addition to Apogee Therapeutics, Inc. (APGE) was in Q2 2026, adding 137,395 shares worth $18.24 M.
According to the latest 13F filing for Q2 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 137,395 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $18.24 M.
As of the Q2 2026 filing, Apogee Therapeutics, Inc. (APGE) represents approximately 0.04% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Apogee Therapeutics, Inc. (APGE) was 137,395 shares, as reported at the end of Q2 2026.